References
For some recent publications see:
1a
Martín R.
Alcón M.
Pericàs MA.
Riera A.
J. Org. Chem.
2002,
67:
6896
1b
Cooper TS.
Larigo AS.
Laurent P.
Moody CJ.
Takle AK.
Synlett
2002,
1730
1c
Pulz R.
Al-Harrasi A.
Reissig H.-U.
Org. Lett.
2002,
4:
2353
1d
Cipolla L.
La Ferla B.
Nicotra F.
Curr. Top. Med. Chem.
2003,
3:
485
1e
Carmona AT.
Fuentes J.
Robina I.
García ERR.
Vogel P.
J. Org. Chem.
2003,
68:
3874
1f
Donohoe TJ.
Headley CE.
Cousins RPC.
Cowley A.
Org. Lett.
2003,
5:
999
1g
Chapman TM.
Courtney S.
Hay P.
Davis BG.
Chem.-Eur. J.
2003,
9:
3397
1h
Singh S.
Chikkanna D.
Singh OV.
Han HS.
Synlett
2003,
1279
1i
García ALL.
Correia CRD.
Tetrahedron Lett.
2003,
44:
1553
1j
Dondoni A.
Perrone D.
Tetrahedron
2003,
59:
4261
1k
Chikkanna D.
Han HS.
Synlett
2004,
2311
1l
Assiego C.
Pino-Gonzalez MS.
Lopez-Herrera FJ.
Tetrahedron Lett.
2004,
45:
2611
1m
Davies SG.
Nicholson RL.
Price PD.
Roberts PM.
Smith AD.
Synlett
2004,
901
1n
Davis AS.
Gates NJ.
Lindsay KB.
Tang MY.
Pyne SG.
Synlett
2004,
40
1o
Badorrey R.
Cativiela C.
Díaz-de-Villegas MD.
Díez R.
Gálvez JA.
Tetrahedron Lett.
2004,
45:
719
1p
Pyne SG.
Davis AS.
Gates NJ.
Hartley JP.
Lindsay KB.
Machan T.
Tang M.
Synlett
2004,
2670
2a
Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond
Stütz AE.
Wiley-VCH;
Weinheim:
1999.
2b
Asano N.
Nash RJ.
Molyneux RJ.
Fleet GWJ.
Tetrahedron: Asymmetry
2000,
11:
1645
3
Lundt I.
Madsen R.
Al Daher S.
Winchester B.
Tetrahedron
1994,
50:
7513 ; and references therein
4a
Setoi H.
Kayakiri H.
Takeno H.
Hashimoto M.
Chem. Pharm. Bull.
1987,
35:
3995
4b
Fleet GWJ.
Son JC.
Green DSC.
Cenci di Bello I.
Winchester B.
Tetrahedron
1988,
44:
2649
4c
Buchanan JG.
Lumbard KW.
Sturgeon RJ.
Thompson DK.
Wightman RH.
J. Chem. Soc., Perkin Trans. 1
1990,
699
4d
Lundt I.
Madsen R.
Synthesis
1992,
714
5
Badorrey R.
Cativiela C.
Díaz-de-Villegas MD.
Díez R.
Gálvez JA.
Eur. J. Org. Chem.
2003,
2268
6
Trnka TM.
Grubbs RH.
Acc. Chem. Res.
2001,
34:
18
7
Sharpless KB.
Amberg W.
Bennari YL.
Crispino GA.
Hartung J.
Jeong KS.
Kwong HL.
Morikawa K.
Wang ZM.
Xu D.
Zan XL.
J. Org. Chem.
1992,
57:
2768
8 Spectral data for compound 6: 1H NMR (400 MHz, CDCl3): δ = 3.24 [dd, 1 H, J = 10.7 Hz, J = 3.2 Hz, CH
2
(OC)CH- (OC)CHN], 3.29 [dd, 1 H, J = 10.7 Hz, J = 5.6 Hz,
CH
2
(OC)CH(OC)CHN], 3.81 [ddd, 1 H, J = 5.6 Hz, J = 5.6 Hz, J = 3.2 Hz, CH2(OC)CH(OC)CHN], 4.04 (d, 1 H, J = 15.2, NCH
2
Ph), 4.07 [ddd, 1 H, J = 5.6 Hz, J = 3.2 Hz, J = 1.6 Hz, CH2(OC)CH(OC)CHN], 4.32 (s, 2 H, OCH
2
Ph), 4.42 (d, 1 H, J = 11.6 Hz, OCH
2
Ph), 4.59 (d, 1 H, J = 11.6 Hz, OCH
2
Ph), 4.95 (d, 1 H, J = 15.2 Hz, NCH
2
Ph), 6.12 (dd, 1 H, J = 6.0 Hz, J = 1.6 Hz, NCHCH=CHCO), 6.99-7.02 (m, 3 H, NCHCH=CHCO, CH
arom), 7.15-7.29 (m, 15 H, CH
arom). 13C NMR (100 MHz, CDCl3): δ = 44.5, 63.1, 69.2, 72.4, 73.3, 76.8, 127.4, 127.5, 127.7, 127.8, 128.3, 128.6, 137.1, 137.5, 137.6, 145.5, 145.6, 171.6
9
Nishimura S. In Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis
John Wiley and Sons;
New York:
2001.
10
Nájera C.
Yus M.
Tetrahedron: Asymmetry
1999,
10:
2245